167 related articles for article (PubMed ID: 22525255)
21. Malignant melanoma: correlating abdominal and pelvic CT with clinical staging.
Shirkhoda A; Albin J
Radiology; 1987 Oct; 165(1):75-8. PubMed ID: 3628793
[TBL] [Abstract][Full Text] [Related]
22. Classification and staging of melanoma.
Gershenwald JE; Buzaid AC; Ross MI
Hematol Oncol Clin North Am; 1998 Aug; 12(4):737-65. PubMed ID: 9759577
[TBL] [Abstract][Full Text] [Related]
23. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
[TBL] [Abstract][Full Text] [Related]
24. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma.
Kersey PA; Iscoe NA; Gapski JA; Osoba D; From L; DeBoer G; Quirt IC
Br J Surg; 1985 Aug; 72(8):614-7. PubMed ID: 4027532
[TBL] [Abstract][Full Text] [Related]
25. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
26. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
27. Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma.
DeRose ER; Pleet A; Wang W; Seery VJ; Lee MY; Renzi S; Sullivan RJ; Atkins MB
Melanoma Res; 2011 Aug; 21(4):364-9. PubMed ID: 21540750
[TBL] [Abstract][Full Text] [Related]
28. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP
Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
30. [Computed tomography evaluation of metastasis of cutaneous melanoma].
Potente G; Cantisani C; Cantisani V; Bottoni U; Calvieri S; Andreoli GM; Arduini F; Guerrisi R
Radiol Med; 2001 Apr; 101(4):275-80. PubMed ID: 11398059
[TBL] [Abstract][Full Text] [Related]
31. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma.
Saiag P; Bernard M; Beauchet A; Bafounta ML; Bourgault-Villada I; Chagnon S
Arch Dermatol; 2005 Feb; 141(2):183-9. PubMed ID: 15724014
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography for staging and management of malignant melanoma.
Prichard RS; Hill AD; Skehan SJ; O'Higgins NJ
Br J Surg; 2002 Apr; 89(4):389-96. PubMed ID: 11952577
[TBL] [Abstract][Full Text] [Related]
33. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
34. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
35. Contemporary surgical treatment of advanced-stage melanoma.
Essner R; Lee JH; Wanek LA; Itakura H; Morton DL
Arch Surg; 2004 Sep; 139(9):961-6; discussion 966-7. PubMed ID: 15381613
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.
Vereecken P; Laporte M; Petein M; Steels E; Heenen M
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):66-73. PubMed ID: 15649194
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
[TBL] [Abstract][Full Text] [Related]
39. Laboratory tests and imaging studies in patients with cutaneous malignant melanoma.
Huang CL; Provost N; Marghoob AA; Kopf AW; Levin L; Bart RS
J Am Acad Dermatol; 1998 Sep; 39(3):451-63. PubMed ID: 9738782
[TBL] [Abstract][Full Text] [Related]
40. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging.
Bronstein Y; Ng CS; Rohren E; Ross MI; Lee JE; Cormier J; Johnson VE; Hwu WJ
AJR Am J Roentgenol; 2012 Apr; 198(4):902-8. PubMed ID: 22451559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
